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ABSTRACT Antibodies prepared against chemically synthe-
sized peptides predicted from the DNA sequence have been used
to identify the polypeptides encoded in the ATPase 6 gene and in
unidentified reading frames (URFs) 1 and 3 of human mtDNA.
In particular, antibodies directed against the COOH-terminal
nonapeptide of the putative polypeptide encoded in the ATPase
6 reading frame immunoprecipitated specifically component 17 of
the HeLa cell mitochondrial translation products, the reaction being
inhibited by the specific peptide. Similarly, antibodies directed
against the COOH-terminal undecapeptide of the putative URF1
product or against the COOH-terminal heptapeptide of the pre-
sumptive URF3 product were effective in immunoprecipitating
specifically component 12 or, respectively, component 24 of the
mitochondrial translation products. The sizes of proteins 17, 12,
and 24, as estimated from their electrophoretic mobilities, are
compatible with their being the products of the ATPase 6 gene,
URFI, and URF3, respectively.
The recent sequence analysis of human mtDNA (1) has re-
vealed that this genome has an informational content larger than
previously suspected. In fact, besides five structural genes ho-
mologous to known genes of yeast and Neurospora crassa
mtDNA, eight significant reading frames (>200 nucleotides)
have been found (Fig. 1). These reading frames are perfectly
conserved in their size and mapping position in mouse (5), bo-
vine (6), and rat (7, 8) mtDNAs. With the aims of determining
whether these unidentified reading frames (URFs) are ex-
pressed in human mitochondria and of identifying their protein
products among the mitochondrially synthesized polypeptides
(9), we have taken advantage of a recently developed approach
(for review, see ref. 10) and used antibodies directed against
synthetic peptides corresponding to specific regions of the URFs
(11). By using this approach, we have identified (11) the prod-
uct of the smallest among the human URFs, URFA6L, a 207-
nucleotide-long reading frame overlapping out of phase the
ATPase 6 gene (Fig. 1), as corresponding to component 25 of
the mitochondrial translation products in HeLa cells (9).
Only one mRNA, RNA 14 (12), has been found to map in the
region of URFA6L and of the ATPase 6 gene of human mtDNA
(2). Because of the interesting questions that the unusual or-
ganization of these two genes raise concerning the translation
of their products, it seemed important to show that the ATPase
6 gene is expressed in HeLa cells. In the present work, the use
of antibodies directed against a synthetic peptide predicted from
the DNA sequence has led to the identification, among the mi-
tochondrially synthesized polypeptides of HeLa cells, of com-
ponent 17 as the product of the ATPase 6 gene. By the same
FIG. 1. Genetic and transcriptional maps of the HeLa cell mito-
chondrial genome (1, 2). The two outer circles show the positions of the
two rRNA genes, as derived from mapping andRNA sequence analysis
experiments (2, 3), and those of the tRNA genes, as derived from the
mtDNA sequence (1). Mapping positions (2) of the polyadenylylated H-
strand transcripts are indicated by black bars and those ofthe L-strand
transcripts, by hatched bars. Left and right arrows indicate the direc-
tion of H- and L-strand transcription, respectively; the vertical arrow
(marked 0) and the rightward arrow at the top indicate the location of
the origin and the direction ofH-strand synthesis. The two inner circles
show the positions of the mtDNA reading frames (1). Modified from ref.
4.
approach, components 12 and 24 (9) have been identified as the
products of URF1 and URF3, respectively.
MATERIALS AND METHODS
Peptide Synthesis and Attachment to Carrier Proteins and
Preparation of Antisera. The techniques used for the synthesis
and characterization of the peptides, their attachment to bo-
vine serum albumin or horse myoglobin, and the preparation
and testing of antisera have been described (11, 13).
Abbreviation: URF, unidentified reading frame.
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Preparation and Testing of Gamma Globulin and Removal
of Anti-Bovine Serum Albumin Antibodies. A gamma globulin
fraction was obtained from the antisera and from one normal
rabbit serum by a single precipitation with 33% (NH4)2SO4 and
freed of anti-bovine serum albumin antibodies by two consec-
utive passages through a column of bovine serum albumin con-
jugated to Sepharose 4B (Pharmacia). The immunoreactivity of
the final gamma globulin preparations against the synthetic
peptides was tested by a solid-phase radioimmunoassay (11).
Labeling and Immunoprecipitation of Mitochondrial Trans-
lation Products and Analysis of Immunoprecipitate. HeLa cells
were labeled with [35S]methionine in the presence of emetine
(9), and the mitochondrial fraction was isolated and sonicated
as described (11). Immunoprecipitation of the products and
electrophoretic analysis of the immunoprecipitate was carried
out as detailed (11). In some experiments, the immunoprecip-
itate was electrophoresed through a linear gradient polyacryl-
amide gel (9).
Analysis of Crossreactivity of Antipeptide Antibodies by Solid-
Phase Radioimmunoassay. This was carried out by the previ-
ously described radioimmunoassay (11), modified as described
below. A solution (1 mg/ml) of the particular myoglobin-pep-
tide conjugate (the degree of substitution was 26 peptides
URFA6L-C, 16 peptides URF1-C, 20 peptides ATPase 6-C per
myoglobin molecule), or of horse myoglobin, or of human fi-
brinogen was deposited in each well of a microtiter plate, and
the wells were washed twice with phosphate-buffered saline
containing ovalbumin (4 mg/ml), with the last solution being
left for 2 hr at room temperature. Then, the antiserum at var-
ious dilutions was deposited in the wells and left for 1 hr at 37GC.
After this, the wells were washed three times with 0.05% Non-
idet P-40 in phosphate-buffered saline, and 125,000 cpm of 125I-
labeled goat anti-rabbit gamma globulin (5-10 x 105 cpm/,ug)
was deposited in each well and left for 1 hr at 37°C. Finally, the
wells were washed three times with Nonidet P-40/phosphate-
buffered saline, their bottoms were cut out, and radioactivity
was determined in a gamma counter.
RESULTS
Preparation of Antipeptide Antibodies. In the present work,
a COOH-terminal sequence of the putative products of the
ATPase 6 gene and of URF1 and two COOH-terminal se-
quences of different lengths of URF3 were chosen for chemical
synthesis. Table 1 shows the sequences of the peptides syn-
thesized, their mode of attachment to bovine serum albumin,
and the degree of substitution obtained. The preparation of
antibodies against a COOH-terminal undecapeptide of cyto-
chrome c oxidase subunit II (COII) (anti-COII-C) has been de-
scribed (11).
Immunoprecipitation of Mitochondrial Translation Prod-
ucts with Anti-ATPase 6-C Antibodies. Immunoprecipitation
tests were carried out using a HeLa cell mitochondrial lysate,
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FIG. 2. Fluorograms, after electrophoresis through NaDodSO4/
urea/polyacrylamide gels (A and C) or a NaDodSO4/gradient poly-
acrylamide gel (B), ofthe HeLa cell mitochondrial translation products
immunoprecipitated by anti-ATPase 6-C or anti-COII-C antibodies. (A
and B) Immunoprecipitation tests using [35S]methionine-labeled mi-
tochondrial translation products and 1 mg of gamma globulin from an
anti-ATPase 6-C (lanes 2 and 6) or an anti-COII-C (lanes 3 and 5) anti-
serum, freed of anti-bovine serum albumin antibodies. A control ex-
periment using 1 mg of gamma globulin from a normal rabbit serum
is shown in lane 4. (C) Immunoprecipitation tests using 1 mg ofgamma
globulin from an anti-ATPase 6-C antiserum in the absence (lane 9) or
presence (lane 10) of 20 ,ug of ATPase 6-C peptide. Lanes 1, 7, and 8:
pattern of mitochondrial translation products.
labeled with [3S]methionine under conditions selective for mi-
tochondrial protein synthesis, and gamma globulin from an
antiserum directed against the COOH-terminal peptide of the
putative ATPase 6 gene product (anti-ATPase 6-C), freed of anti-
bovine serum albumin antibodies. After NaDodSO4/urea/
polyacrylamide gel electrophoresis of the immunoprecipitated
material and fluorography, a distinct band with a mobility cor-
responding to that of the band designated "17,18" in the profile
of HeLa cell mitochondrial translation products (9) was ob-
served (Fig. 2A). Only a barely visible band, representing non-
specific background, was present at the same position in the
immunoprecipitate obtained with anti-COII-C gamma globu-
lin.
Previous work (9) had shown that the two components form-
ing band "17,18" can be resolved in a different gel system-i.e.,
a linear gradient polyacrylamide slab gel, with component 17,
which is the major one, migrating slower than COIl [rather than
Table 1. Synthetic peptides and modes of attachment
Attachment Degree of
Source Sequencet procedure substitution*
ATPase 6 (carboxyl terminus) (Lys)Val-Ser-Leu-Tyr-Leu-His-Asp-Asn-Thr Glutaraldehyde 21
(n = 10)
URF1 (carboxyl terminus) (Lys)Pro-lle-Thr-Ile-Ser-Ser-Ile-Pro-Pro-Gln-Thr Glutaraldehyde 26
(n = 12)
URF3 (carboxyl terminus) 1 Lys-Gly-Leu-Asp-Trp-Thr-Glu Glutaraldehyde 35
2 (Tyr)Leu-Gln-Lys-Gly-Leu-Asp-Trp-Thr-Glu Bisdiazobenzidine 28
tResidues in parentheses were incorporated for attachment purposes. *, Radioactive residue.
tNumber of peptide molecules per bovine serum albumin molecule.
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faster, as in the urea gel system (Fig. 2A)], and component 18
moving faster than COIL. As shown in Fig. 2B, in this gradient
gel system, a pronounced band with mobility corresponding to
that of component 17 was visible in the pattern of the products
precipitated by anti-ATPase 6-C antibodies, while the COII
polypeptide precipitated by anti-COII antibodies formed a band
at the expected position. Fig. 2C shows that the ATPase 6 COOH-
terminal peptide (added in the amount of 20 Ag) competed al-
most completely (=80%) with component 17 in the precipita-
tion by the antipeptide antibodies (the competition was essen-
tially complete with a larger amount of peptide), confirming the
specificity of the reaction.
In the electrophoretic pattern of the immunoprecipitate ob-
tained with anti-ATPase 6-C gamma globulin, a very faint band,
absent in the control lanes, could be seen after long exposure
of the autoradiogram (arrow in Fig. 2 A and B). In both the urea
gel pattern (Fig. 2A) and the gradient polyacrylamide gel pat-
tern (Fig. 2B), this band had a mobility similar to that of com-
ponent 21. It seems possible that this peptide represents a
COOH-terminal degradation fragment of ATPase 6.
Immunoprecipitation of Mitochondrial Translation Prod-
ucts with Anti-URFl-C Antibodies. Fig. 3A shows the elec-
trophoretic pattern in a NaDodSO4/urea/polyacrylamide gel
of the [35S]methionine-labeled components immunoprecipi-
tated by anti-URFl-C gamma globulin. One can see a pro-
nounced band with a mobility corresponding to that of com-
ponent 12 and a less pronounced band migrating as protein 25,
which are absent in the immunoprecipitate obtained with gamma
globulin from an anti-URF3-C antiserum. After electrophoresis
of the immunoprecipitated components through a NaDodSO4/
gradient polyacrylamide gel (Fig. 3B), one can see likewise a
pronounced band with a mobility identical to that of component
12 and a less pronounced band migrating as protein 25, which
are absent in the control immunoprecipitate obtained with nor-
mal serum gamma globulin.
In previous work (11), it had been observed that anti-URFA6L-
C antibodies, but not anti-URFA6L-N antibodies, precipitated
component 12, although with a much lower efficiency (10-20%),
as compared with protein 25. This crossreactivity of component
12 and protein 25 with anti-URFA6L-C antibodies had been
interpreted as suggesting that protein 12 is the product of URF1;
in fact, this is the only one among the potential human mtDNA
gene products deduced from the DNA sequence that shows sig-
nificant sequence homology (occurring in its COOH-terminal
nonapeptide) to the COOH-terminal nonapeptide of protein 25
(see Discussion). The present results have corroborated the above
interpretation by revealing that there is also a crossreactivity of
component 12 and protein 25 with the anti-URFl-C antibodies.
From densitometric measurements, one can estimate that the
efficiency of immunoprecipitation of component 25 by anti-
URF1-C antibodies was about 60% of that observed for com-
ponent 12. Fig. 3D shows that 20 ug of the COOH-terminal
peptide of the URF1 product competed completely with both
protein 12 and protein 25 in the precipitation by antipeptide
antibodies.
Quantitation of the Crossreactivity of the URF1-C and
URFA6L-C Peptides with Each of the Corresponding Anti-
sera. To quantitate the crossreactivity of the two specific pep-
tides with the anti-URF1-C or anti-URFA6L-C antibodies,
without interference by the rest of the molecule or by the
NaDodSO4 present in the immunoprecipitation mixture, solid-
phase radioimmunoassays were carried out using myoglobin-
URF1-C peptide and myoglobin-URFA6L-C peptide conju-
gates as antigens, anti-URFl-C and anti-URFA6L-C antisera,
and "2I-labeled goat anti-rabbit gamma globulin. The URF1-C
and URFA6L-C peptides appeared to crossreact almost com-
pletely with the anti-URFl-C antiserum, with a slightly stronger
reaction of the antiserum with the URF1-C peptide at the higher
dilutions (Fig. 4a). By contrast, the URF1-C peptide cross-
reacted incompletely with the URFA6L-C peptide vs. the anti-
URFA6L-C antiserum, especially in the higher dilution range
(60-70%) (Fig. 4b). No reaction with myoglobin or the myoglo-
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FIG. 3. Fluorograms, after electrophoresis through NaDodSO4/urea/polyacrylamide gels (A and D) or NaDodSO4/gradient polyacrylamide
gels (B and C) of the HeLa cell mitochondrial translation products immunoprecipitated by anti-URF1-C or anti-URF3-C antibodies. (A-C) Im-
munoprecipitation tests using [35S]methionine-labeled mitochondrial translation products and 1 mg ofgamma globulin from an anti-URF1-C (lanes
2 and 6) or an anti-URF3-C (lanes 3, 7 and 9) antiserum, freed of anti-bovine serum albumin antibodies. A control experiment using 1 mg ofgamma
globulin from a normal rabbit serum is also shown (lane 5). (D) Immunoprecipitation tests using 1 mg of gamma globulin from an anti-URF1-C
antiserum in the absence (lane 11) or presence (lane 12) of 20 ,ug of URF1-C peptide or using 1 mg of gamma globulin from an anti-URF3-Cl anti-
serum in the absence (lane 13) or presence (lane 14) of 20 ,Ag of URF3-C1 peptide. Lanes 1, 4, 8 and 10: pattern of mitochondrial translation products.
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FIG. 4. Reactivity of anti-URF1-C antiserum (a) or anti-URFA6L-
C antiserum (b) with myoglobin-URF1-C conjugate (0), myoglobin-
URFA6L-C conjugate (o), horse myoglobin (x), myoglobin-ATPase 6-
C conjugate (A), or human fibrinogen (i).
bin-ATPase 6-C peptide was exhibited by either the anti-URFl-
C or the anti-URFA6L-C antiserum.
Immunoprecipitation of Mitochondrial Translation Prod-
ucts with Anti-URF3-C Antibodies. The initial tests by solid-
phase radioimmunoassay (11) showed that the anti-URF3-Cl
antiserum reacted equally well with URF3-C1 and URF3-C2
(Table 1); the same was true for anti-URF3-C2 antiserum. How-
ever, surprisingly, the anti-URF3-Cl antiserum was about 10
times more active than the anti-URF3-C2 antiserum; by con-
trast, the two antisera were similarly active when tested against
bovine serum albumin. This result suggested that the COOH-
terminal nonapeptide was much less immunogenic than the
COOH-terminal heptapeptide. Therefore, the anti-URF3-Cl
antiserum was used in subsequent experiments.
Analysis in a NaDodSO4/urea/polyacrylamide gel of the
[35S]methionine-labeled material immunoprecipitated by anti-
URF3-C1 gamma globulin revealed a distinct band, with a mo-
bility corresponding to that of the band designated "23,24" in
the profile of HeLa cell mitochondrial translation products (9)
(Fig. 3A); only a very faint band is visible at the same position
in the immunoprecipitate obtained with anti-URFl-C gamma
globulin. In a NaDodSO4/linear gradient polyacrylamide slab
gel, the component precipitated by anti-URF3-Cl gamma glob-
ulin again migrated with the same mobility as the unresolved
components "23,24" (Fig. 3B). In an electrophoretic run in the
same gel system in which components 23 and 24 were resolved,
the immunoprecipitated component could be identified as
component 24 (Fig. 3C). Fig. 3D shows that 20 ,ug of the COOH-
terminal peptide of the URF3 product competed completely
with protein 24 in the precipitation by the antipeptide anti-
bodies.
DISCUSSION
Identity of the Polypeptides Precipitated by the Antipeptide
Antibodies. Component 17 of the HeLa cell mitochondrial
translation products, the polypeptide specifically precipitated
in this work by anti-ATPase 6-C antibodies, has been estimated
to have a size of 16,000 daltons on the basis of its electro-
phoretic mobility in a NaDodSO4/urea/polyacrylamide gel (9).
This size is smaller by 33% than that expected for the protein
encoded in the ATPase 6 reading frame [24,000 daltons (1)].
However, it has been shown that NaDodSO4/polyacrylamide
gel A4ectrophoresis has a tendency to give underestimates, by
20-40%, of the size of the mtDNA-encoded hydrophobic pro-
teins relative to the size expected from the DNA sequence (1,
14-17). Furthermore, in the case of component 17, a process-
ing step at the NH2 terminus could conceivably contribute to
the apparent difference in size from the expected one.
The same bias in the size estimates based on NaDodSO4/
polyacrylamide gel electrophoresis data is probably responsible
in major part, if not completely, for the discrepancies between
the expected size of the URF1 product [35,600 daltons (1)] and
the estimated size of protein 12, precipitated by anti-URF1 an-
tibodies [=24,000 daltons (9)], and between the expected size
of the URF3 product [13,200 daltons (1)] and the estimated size
of the immunoprecipitated component 24 [=6,000 daltons (9)].
It should also be noted that, apart from a possible processing,
secondary modifications of the primary translation products could
also affect their electrophoretic mobilities in a NaDodSO4/urea/
polyacrylamide gel.
The specificity of the individual immunoprecipitation re-
actions and the general agreement of the sizes of the immu-
noprecipitated components with the expected ones support the
conclusion that the polypeptides recognized by the antipeptide
antibodies are the true gene products of the ATPase 6 gene and
of URF1 and URF3. In agreement with previous experience
(10, 11), the COOH-terminal peptide of the products of the
reading frames investigated here has proven in all cases to be
both immunogenic and capable of reacting, in the intact pro-
tein, with the antipeptide antibodies under the conditions cho-
sen for immunoprecipitation. Unexpected, however, was the
observation that the COOH-terminal nonapeptide of URF3-C
was much less immunogenic than the COOH-terminal hepta-
peptide.
Mechanism of Expression of the ATPase 6 Gene. The evi-
dence obtained in this and in previous work (11) that the
ATPase 6 gene and URFA6L are both expressed in human mi-
tochondria raises intriguing questions concerning the mecha-
nism whereby the products of these two overlapping genes are
synthesized. A single H-strand-encoded RNA, polyadenylyl-
ated RNA 14 (12), has been found to map in this region of hu-
man mtDNA. This RNA has the unique structural features at
the 5' end and at the 3' end and the characteristic metabolic
properties that have been described for human mitochondrial
mRNAs (18-20). Moreover, on the basis of the available evi-
dence, it seems likely that the same RNA is used not only for
the translation of URFA6L, which is not surprising in view of
its typical 5'-end structure, but also for translation of the
ATPase 6 gene.
In prokaryotic and eukaryotic systems, several examples of
overlapping reading frames are known, and various mecha-
nisms have been proposed to account for their expression (21-
24). In the case of the overlapping URFA6L and ATPase 6 cod-
ing sequences, the lack of a ribosome attachment site, analo-
gous to that present in 7S RNA (25), in the segment of RNA 14
a
b
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FIG. 5. Carboxyl-terminal nonapeptides ofthe putative products of
URF1 and URFA6L.
upstream of the ATPase 6 reading frame speaks against an in-
dependent entry site for ribosomes destined to translate the
downstream reading frame. A possible mechanism operating in
the translation of the ATPase 6 gene is a frameshift of ribo-
somes translating the upstream reading frame, which would re-
sult in premature termination at out-of-phase stop codons, fol-
lowed by reinitiation at the ATPase 6 start codon. Such a
mechanism has been proposed to be responsible for the trans-
lation of the lysis cistron of MS2 RNA, which overlaps out of
phase the coat gene on its 5' end (24). Ribosome slippage on
the mRNA has been suggested as a possible mechanism ac-
counting for the relatively frequent (-5%) phenotypic rever-
sion of a frameshift mutation in yeast mtDNA (26).
The unusual organization of the ATPase 6 gene and of URFA6L
discussed above may have bearing on the physiological role of
the product of URFA6L by analogy with the yeast system. In
mtDNA from both yeast (27) and Aspergillus nidulans (28),
a small URF has recently been discovered upstream of the
ATPase 6 gene. These URFs code for 48-amino acid-long
polypeptides, exhibiting 50% sequence homology with each
other, and having their first four amino acids identical to those
encoded in URFA6L; significantly, mutations in the yeast URF
affect the assembly or function of the ATPase (29), suggesting
a crucial structural or regulatory role of the URF product in
these processes. The proximity of the upstream URF and of the
ATPase 6 gene in the yeast and Aspergillus mtDNAs, the over-
lapping of the putatively homologous genes in mammalian
mtDNA, and the probable translation of the two proteins from
the same mRNA in yeast and mammalian cells may reflect a
link between expression of the two genes.
The Crossreactivity of Proteins 12 and 25 with Anti-URFI-
C or Anti-URFA6L-C Antibodies. The evidence presented here
indicates that the previously observed crossreactivity of com-
ponents 12 and 25 with anti-URFA6L-C antibodies (11) as well
as the crossreactivity detected here of the same proteins with
anti-URFl-C antibodies are due to crossreactivity of the COOH-
terminal peptides of the two proteins. As shown in Fig. 5, the
COOH-terminal nonapeptide of the putative URF1 product
has four out of nine amino acids in common and four others that
are isosteric with or analogous to the amino acids found in the
COOH-terminal nonapeptide of URFA6L. The antibodies against
URF1-C or URFA6L-C showed a greater discriminating power
between the two peptides in the immunoprecipitation exper-
iments carried out with the whole corresponding proteins than
in the reactivity tests carried out by the solid-phase radioim-
munoassay with the peptides conjugated to a carrier protein.
This may reflect a different accessibility of the reacting groups
in the peptide sequences under the two experimental condi-
tions. However, it is interesting that an asymmetry of cross-
reactivity of URF1-C and URFA6L-C when tested with anti-
URFl-C and anti-URFA6L-C antibodies, with the latter anti-
bodies exhibiting a greater discriminating power vs. the two
peptides than the anti-URFl-C antibodies, was observed both
in the immunoprecipitation tests and in the direct tests of cross-
reactivity of the peptides. The crossreactivity detected here and
in previous work between URF1-C and URFA6L-C is inter-
esting because it gives some indication of the lower limit in the
degree of homology between two peptide sequences that al-
lows crossreactivity with antibodies raised against either of the
two peptides.
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